Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001140361-25-021957
Filing Date
2025-06-09
Accepted
2025-06-09 16:30:31
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 8385
2 EXHIBIT 99.1 ef20050335_ex99-1.htm EX-99.1 60623
  Complete submission text file 0001140361-25-021957.txt   70864
Mailing Address 2901 WEST BLUEGRASS BLVD. SUITE 100 LEHI UT 84043
Business Address 2901 WEST BLUEGRASS BLVD. SUITE 100 LEHI UT 84043 (801) 341-7900
NATURES SUNSHINE PRODUCTS INC (Subject) CIK: 0000275053 (see all company filings)

EIN.: 870327982 | State of Incorp.: UT | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-32703 | Film No.: 251034519
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address BUILDING A NO. 1289 YISHAN ROAD SHANGHAI F4 200233
Business Address BUILDING A NO. 1289 YISHAN ROAD SHANGHAI F4 200233 86 21 33987870
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Filed by) CIK: 0001615258 (see all company filings)

EIN.: 000000000 | State of Incorp.: F4 | Fiscal Year End: 1231
Type: SCHEDULE 13D/A